Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region
{{output}}
Background: Most patients treated with erenumab in clinical practice have chronic migraine (CM). We assessed the rate and possible predictors of conversion from CM to episodic migraine (EM) in a real-life study. ... ...
